- Home
- LTRN vs MDAI Comparison
LTRN vs MDAI Comparison
Compare LTRN & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- MDAI
- Stock Information
- Founded
- LTRN 2013
- MDAI 2013
- Country
- LTRN United States
- MDAI United States
- Employees
- LTRN N/A
- MDAI N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- MDAI Medical/Dental Instruments
- Sector
- LTRN Health Care
- MDAI Health Care
- Exchange
- LTRN Nasdaq
- MDAI Nasdaq
- Market Cap
- LTRN 49.9M
- MDAI 51.9M
- IPO Year
- LTRN 2020
- MDAI N/A
- Fundamental
- Price
- LTRN $3.63
- MDAI $1.97
- Analyst Decision
- LTRN Strong Buy
- MDAI Strong Buy
- Analyst Count
- LTRN 1
- MDAI 1
- Target Price
- LTRN $25.00
- MDAI $3.50
- AVG Volume (30 Days)
- LTRN 120.1K
- MDAI 824.1K
- Earning Date
- LTRN 11-14-2025
- MDAI 11-11-2025
- Dividend Yield
- LTRN N/A
- MDAI N/A
- EPS Growth
- LTRN N/A
- MDAI N/A
- EPS
- LTRN N/A
- MDAI N/A
- Revenue
- LTRN N/A
- MDAI $27,549,000.00
- Revenue This Year
- LTRN N/A
- MDAI N/A
- Revenue Next Year
- LTRN N/A
- MDAI $60.05
- P/E Ratio
- LTRN N/A
- MDAI N/A
- Revenue Growth
- LTRN N/A
- MDAI 22.27
- 52 Week Low
- LTRN $2.55
- MDAI $1.01
- 52 Week High
- LTRN $6.12
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- LTRN 38.13
- MDAI 39.35
- Support Level
- LTRN $3.75
- MDAI $2.07
- Resistance Level
- LTRN $4.09
- MDAI $2.18
- Average True Range (ATR)
- LTRN 0.30
- MDAI 0.16
- MACD
- LTRN -0.04
- MDAI -0.05
- Stochastic Oscillator
- LTRN 5.95
- MDAI 7.59
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.